Literature DB >> 19345424

alpha4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions.

Shumei Man1, Barbara Tucky, Nika Bagheri, Xiaolong Li, Rabina Kochar, Richard M Ransohoff.   

Abstract

Insights into sequential leukocyte-endothelial interactions during leukocyte trafficking have been obtained through experiments using human umbilical vein endothelial cells (HUVEC) under flow conditions. To investigate leukocyte-brain endothelial cell interactions, we developed a dynamic in vitro system, using Transfected Human Brain Microvascular Endothelial Cells (THBMEC) and a parallel plate flow chamber. Human peripheral blood mononuclear cells (PBMC) were perfused across confluent THBMEC cultures at a velocity that approximates the rate found in human brain capillaries. Leukocyte-THBMEC interactions were visualized by phase-contrast microscopy, and images were captured on a CCD camera. To simulate inflammatory conditions, we activated THBMEC with the inflammatory cytokines tumor necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma), which up-regulated chemokine and adhesion molecule expression in THBMEC without affecting the distribution of immunoreactivity for tight junction-associated proteins. PBMC adhesion was enhanced by cytokine-mediated activation of THBMEC. G protein-coupled receptor (GPCR) activation was essential for leukocyte-THBMEC interaction, as pertussis toxin (PTX) treatment of PBMC abrogated PBMC adhesion to activated THBMEC. The anti-alpha4 integrin antibody, natalizumab, infused into MS patients, significantly reduced the adhesion of their ex vivo PBMC to activated THBMEC under flow conditions. Further study showed that alternatively spliced fibronectin containing the CS1 region (FN-CS1), but not Vascular Cell Adhesion Molecule type 1 (VCAM-1), was the ligand of alpha4 integrin on activated THBMEC. Blocking FN-CS1 abrogated PBMC adhesion on activated THBMEC, while anti-VCAM-1 antibodies had no effect. These results established a novel in vitro dynamic BBB model. We also demonstrated the dependence of leukocyte-endothelial interactions in this model on alpha4 integrins and FN-CS1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345424      PMCID: PMC2696803          DOI: 10.1016/j.jneuroim.2009.03.008

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  59 in total

Review 1.  Inflammatory mechanisms after ischemia and stroke.

Authors:  Gary H Danton; W Dalton Dietrich
Journal:  J Neuropathol Exp Neurol       Date:  2003-02       Impact factor: 3.685

2.  Alpha4 integrins as therapeutic targets in autoimmune disease.

Authors:  Ulrich H von Andrian; Britta Engelhardt
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

3.  Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin.

Authors:  Pia Kivisäkk; Don J Mahad; Melissa K Callahan; Corinna Trebst; Barbara Tucky; Tao Wei; Lijun Wu; Espen S Baekkevold; Hans Lassmann; Susan M Staugaitis; James J Campbell; Richard M Ransohoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

Review 4.  The role of endothelial cell lateral junctions during leukocyte trafficking.

Authors:  Francis W Luscinskas; Shuo Ma; Asma Nusrat; Charles A Parkos; Sunil K Shaw
Journal:  Immunol Rev       Date:  2002-08       Impact factor: 12.988

5.  Overexpression of the oncofetal Fn variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skin.

Authors:  K M Ting; D Rothaupt; T S McCormick; C Hammerberg; G Chen; A C Gilliam; S Stevens; L Culp; K D Cooper
Journal:  J Invest Dermatol       Date:  2000-04       Impact factor: 8.551

6.  Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.

Authors:  Luc J W van der Laan; Annette van der Goes; Marca H M Wauben; Sigrid R Ruuls; Ed A Döpp; Corline J A De Groot; Taco W Kuijpers; Mariano J Elices; Christine D Dijkstra
Journal:  J Neurosci Res       Date:  2002-01-15       Impact factor: 4.164

7.  Differentiation of polymorphonuclear neutrophils in patients with systemic infections and chronic inflammatory diseases: evidence of prolonged life span and de novo synthesis of fibronectin.

Authors:  C Wagner; M Pioch; C Meyer; C Iking-Konert; K Andrassy; G M Hänsch
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

8.  VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions.

Authors:  John W Peterson; Lars Bö; Sverre Mörk; Ansi Chang; Richard M Ransohoff; Bruce D Trapp
Journal:  J Neuropathol Exp Neurol       Date:  2002-06       Impact factor: 3.685

9.  Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells.

Authors:  Shobha H Ganji; Shucun Qin; Linhua Zhang; Vaijinath S Kamanna; Moti L Kashyap
Journal:  Atherosclerosis       Date:  2008-05-09       Impact factor: 5.162

10.  Analysis of tight junctions during neutrophil transendothelial migration.

Authors:  A R Burns; R A Bowden; S D MacDonell; D C Walker; T O Odebunmi; E M Donnachie; S I Simon; M L Entman; C W Smith
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

View more
  26 in total

1.  CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.

Authors:  Shumei Man; Barbara Tucky; Anne Cotleur; Judith Drazba; Yukio Takeshita; Richard M Ransohoff
Journal:  Sci Transl Med       Date:  2012-02-01       Impact factor: 17.956

Review 2.  Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.

Authors:  Yukio Takeshita; Richard M Ransohoff
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Chaoling Dong; Kelsey M Greathouse; Rebecca L Beacham; Steven P Palladino; E Scott Helton; Eroboghene E Ubogu
Journal:  Exp Neurol       Date:  2017-02-16       Impact factor: 5.330

Review 4.  The anatomical and cellular basis of immune surveillance in the central nervous system.

Authors:  Richard M Ransohoff; Britta Engelhardt
Journal:  Nat Rev Immunol       Date:  2012-08-20       Impact factor: 53.106

5.  Fibronectin-α4β1 interactions in hepatic cold ischemia and reperfusion injury: regulation of MMP-9 and MT1-MMP via the p38 MAPK pathway.

Authors:  S Duarte; X-D Shen; C Fondevila; R W Busuttil; A J Coito
Journal:  Am J Transplant       Date:  2012-07-19       Impact factor: 8.086

Review 6.  Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.

Authors:  Finn Sellebjerg; Diego Cadavid; Deborah Steiner; Luisa Maria Villar; Richard Reynolds; Daniel Mikol
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

7.  Bifurcations: focal points of particle adhesion in microvascular networks.

Authors:  Balabhaskar Prabhakarpandian; Yi Wang; Angela Rea-Ramsey; Shivshankar Sundaram; Mohammad F Kiani; Kapil Pant
Journal:  Microcirculation       Date:  2011-07       Impact factor: 2.628

8.  α(M)β(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro.

Authors:  Nejla Yosef; Eroboghene E Ubogu
Journal:  J Cell Physiol       Date:  2012-12       Impact factor: 6.384

9.  Angiopoietin-1/Tie2 signaling pathway contributes to the therapeutic effect of thymosin β4 on diabetic peripheral neuropathy.

Authors:  Lei Wang; Michael Chopp; Alexandra Szalad; XueRong Lu; Mei Lu; Talan Zhang; Zheng Gang Zhang
Journal:  Neurosci Res       Date:  2018-10-13       Impact factor: 3.304

Review 10.  Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.

Authors:  Ana J Coito
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.